In Alzheimer’s disease (AD), a condition characterized by the accumulation of amyloid-β (Aβ) peptides and hyperphosphorylated tau aggregates, IL-1 family cytokines have emerged as key players in driving the associated chronic inflammatory state. Here, MAPT is linked to Alzheimer disease.